Assessment of neurological function using the National Institute of Health Stroke Scale in patients with gliomas.
Anna Maria ZeitlbergerMarie-Claire FlynnMonika HollensteinThomas HundsbergerPublished in: Neuro-oncology practice (2021)
The application of the NIHSS is easy and feasible in the heterogeneous population of glioma patients. In our cohort, the RANO categories did not reflect contemporaneous changes in the NIHSS. A validated clinical outcome measure with a well-defined minimal clinically important difference is warranted in neuro-oncological research and clinical practice.
Keyphrases
- end stage renal disease
- clinical practice
- chronic kidney disease
- healthcare
- ejection fraction
- public health
- atrial fibrillation
- peritoneal dialysis
- prostate cancer
- mental health
- prognostic factors
- high grade
- rectal cancer
- quality improvement
- risk assessment
- social media
- minimally invasive
- health information
- radical prostatectomy
- climate change
- robot assisted
- human health
- clinical evaluation